Are You Prepped? Pre and Post Exposure Prophylaxis for Dermatologists

In this presentation, John Zampella, an Associate Professor of Dermatology at NYU, discusses the importance of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for dermatologists, particularly as they relate to sexually transmitted infections (STIs) and HIV. He emphasizes that dermatologists should not only treat conditions like secondary syphilis but also inquire about patients' risk factors for HIV and other STIs. Zampella explains both PrEP, which involves taking medication routinely to prevent infections, and PEP, which is administered after potential exposure to pathogens. He notes the significant rise in STIs and how PrEP has been shown to reduce HIV transmission rates by up to 99% when taken consistently. The talk includes specific instances when dermatologists should consider prescribing these medications, such as patients with recent STIs or those expressing interest in prevention methods. Zampella clarifies the different types of medications available, such as Truvada and its newer counterparts, and the importance of thorough sexual histories and follow-up care. The session also covers the administration of doxycycline for bacterial STIs prophylaxis post-exposure, recent studies supporting its efficacy, and potential side effects or concerns surrounding antibiotic resistance. In conclusion, Zampella encourages dermatologists to become familiar with PrEP and PEP to better serve their patients and improve public health outcomes.